THERE HAS BEEN controversy regarding the appropriate use of magnetic resonance (MR) contrast agents in the evaluation of central nervous system (CNS) tumors. When MR imaging was first available in clinical practice in the early 1980s. contrast agents were thought to be unnecessary because of the exc
Contrast enhancement issues in the MR evaluation of the central nervous system
β Scribed by Colosimo, C.; Manfredi, R.; Tartaglione, T.
- Book ID
- 113012076
- Publisher
- Springer
- Year
- 1997
- Tongue
- English
- Weight
- 359 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0938-7994
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract A group of 70 professional divers and 47 healthy control subjects who had never dived were examined with magnetic resonance (MR) imaging to determine the prevalence of focal white matter changes in the brain. Spots of high signal intensity in white matter on proton densityβand/or T2βwei
## Abstract This brief review covers the evolving clinical role of paramagnetic contrast agents in magnetic resonance imaging of the central nervous system, with particular emphasis on potential pitfalls. The safety and efficacy of GdβDTPA is now wellβestablished. Approximately 35β40% of all scans